Prediction of anaphylaxis during peanut food challenge: usefulness of the peanut skin prick test (SPT) and specific IgE level.

作者: Brynn Kevin Wainstein , Jennie Studdert , Mary Ziegler , John B. Ziegler

DOI: 10.1111/J.1399-3038.2010.01063.X

关键词:

摘要: Cutoffs (decision points) of the peanut skin prick test (SPT) and specific IgE level for predicting allergy have been proposed. It is not known whether decision points indicating a significant risk severe reactions on challenge differ from those probable allergy. We aimed at determining usefulness tests anaphylaxis following ingestion up to 12 g in peanut-sensitized children. Children attending Allergy Clinic who had positive SPT completed open-label in-hospital challenges were included. The protocol provided be continued beyond initial mild reactions. Eighty-nine performed. Thirty-four excluded as was completed, leaving 55 analysis. did react (n = 28) or reacted without 6) represented comparison group 34). study comprised 21 children whose resulted anaphylaxis. mean wheal size associated with severity challenge. Among children, developed anaphylaxis, only 3 cases reaction. Unexpectedly, history predictive Anaphylaxis cumulative doses ranging 0.02 11.7 g. Provided that fixed amount ingested, available may assist during

参考文章(39)
Steve L. Taylor, Susan L. Hefle, Carsten Bindslev-Jensen, S.Allan Bock, A.Wesley Burks, Lynn Christie, David J. Hill, Arne Host, Jonathan O’B. Hourihane, Gideon Lack, Dean D. Metcalfe, Denise Anne Moneret-Vautrin, Peter A. Vadas, Fabienne Rance, Daniel J. Skrypec, Thomas A. Trautman, Ingrid Malmheden Yman, Robert S. Zeiger, Factors affecting the determination of threshold doses for allergenic foods: how much is too much? The Journal of Allergy and Clinical Immunology. ,vol. 109, pp. 24- 30 ,(2002) , 10.1067/MAI.2002.120564
A. T. Clark, P. W. Ewan, Interpretation of tests for nut allergy in one thousand patients, in relation to allergy or tolerance Clinical & Experimental Allergy. ,vol. 33, pp. 1041- 1045 ,(2003) , 10.1046/J.1365-2745.2003.01624.X
Scott H. Sicherer, Terence J. Furlong, Anne Muñoz-Furlong, A.Wesley Burks, Hugh A. Sampson, A voluntary registry for peanut and tree nut allergy: Characteristics of the first 5149 registrants☆ Journal of Allergy and Clinical Immunology. ,vol. 108, pp. 128- 132 ,(2001) , 10.1067/MAI.2001.115755
Helen S. Skolnick, Mary Kay Conover-Walker, Celide Barnes Koerner, Hugh A. Sampson, Wesley Burks, Robert A. Wood, The natural history of peanut allergy. The Journal of Allergy and Clinical Immunology. ,vol. 107, pp. 367- 374 ,(2000) , 10.1067/MAI.2001.112129
Scott H. Sicherer, Ellen H. Morrow, Hugh A. Sampson, Dose-response in double-blind, placebo-controlled oral food challenges in children with atopic dermatitis. The Journal of Allergy and Clinical Immunology. ,vol. 105, pp. 582- 586 ,(2000) , 10.1067/MAI.2000.104941
R. S. H. PUMPHREY, S. J. STANWORTH, The clinical spectrum of anaphylaxis in north‐west England Clinical & Experimental Allergy. ,vol. 26, pp. 1364- 1370 ,(1996) , 10.1111/J.1365-2222.1996.TB00537.X
Fabienne Rancé, Michel Abbal, Valérie Lauwers-Cancès, Improved screening for peanut allergy by the combined use of skin prick tests and specific IgE assays. The Journal of Allergy and Clinical Immunology. ,vol. 109, pp. 1027- 1033 ,(2002) , 10.1067/MAI.2002.124775
Richard Pumphrey, Anaphylaxis: can we tell who is at risk of a fatal reaction? Current Opinion in Allergy and Clinical Immunology. ,vol. 4, pp. 285- 290 ,(2004) , 10.1097/01.ALL.0000136762.89313.0B
Pumphrey, Lessons for management of anaphylaxis from a study of fatal reactions Clinical & Experimental Allergy. ,vol. 30, pp. 1144- 1150 ,(2000) , 10.1046/J.1365-2222.2000.00864.X
Jonathan O'B. Hourihane, Sally A. Kilburn, Julie A. Nordlee, Susan L. Hefle, Steve L. Taylor, John O. Warner, An evaluation of the sensitivity of subjects with peanut allergy to very low doses of peanut protein: A randomized, double-blind, placebo-controlled food challenge study The Journal of Allergy and Clinical Immunology. ,vol. 100, pp. 596- 600 ,(1997) , 10.1016/S0091-6749(97)70161-1